Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amos Burke GA"'
Autor:
Trigg, Ricky M, Lee, Liam C, Prokoph, Nina, Jahangiri, Leila, Reynolds, C Patrick, Amos Burke, GA, Probst, Nicola A, Han, Miaojun, Matthews, Jamie D, Lim, Hong Kai, Manners, Eleanor, Martinez, Sonia, Pastor, Joaquin, Blanco-Aparicio, Carmen, Merkel, Olaf, De Los Fayos Alonso, Ines Garces, Kodajova, Petra, Tangermann, Simone, Högler, Sandra, Luo, Ji, Kenner, Lukas, Turner, Suzanne D
Resistance to anaplastic lymphoma kinase (ALK)-targeted therapy in ALK-positive non-small cell lung cancer has been reported, with the majority of acquired resistance mechanisms relying on bypass signaling. To proactively identify resistance mechanis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::751616d1e43bbf8afb551635a65b0ab1
Autor:
Lueza B; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France., Aupérin A; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France., Rigaud C; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France., Gross TG; Department of Pediatrics, Center for Cancer and Blood Diseases, Children's Hospital Colorado, Aurora, CO, USA., Pillon M; Pediatric Hematology and Oncology, University of Padova, Padua, Italy., Delgado RF; Pediatric Hematology and Oncology, University of Valencia, Valencia, Spain., Uyttebroeck A; Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Louvain, Belgium., Amos Burke GA; Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK., Zsíros J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Csóka M; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary., Simonin M; Department of Pediatric Oncology and Hematology, Armand Trousseau Hospital-APHP, Sorbonne University, Paris, France., Patte C; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France., Minard-Colin V; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.; INSERM 1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Bonastre J; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France. julia.bonastre@gustaveroussy.fr.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France. julia.bonastre@gustaveroussy.fr.
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2024 Mar; Vol. 25 (2), pp. 307-317. Date of Electronic Publication: 2023 Apr 14.
Autor:
Garland GD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK., Ducray SP; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK., Jahangiri L; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK.; Department of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK., Pucci P; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK., Amos Burke GA; Department of Paediatric Oncology, Cambridge University Hospital NHS Trust, Cambridge CB5 8PD, UK., Monahan J; The European Bioinformatics Institute (EMBL EBI), Wellcome Genome Campus, Cambridge CB10 1SA, UK., Lai R; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada., Merkel O; Department of Pathology, Medical University Vienna, 1090 Vienna, Austria., Schiefer AI; Department of Pathology, Medical University Vienna, 1090 Vienna, Austria., Kenner L; Department of Pathology, Medical University Vienna, 1090 Vienna, Austria.; Unit of Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.; CBMed, 8010 Graz, Austria.; Christian Doppler Laboratory of Applied Metabolomics (CDL-AM), Medical University Vienna, 1090 Vienna, Austria., Bannister AJ; The Gurdon Institute, Cambridge CB2 1QN, UK., Turner SD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK.; Central European Institute of Technology (CEITEC), Masaryk University, 601 77 Brno, Czech Republic.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 29; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 29.
Autor:
Trigg RM; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.; Functional Genomics, Medicinal Science & Technology, GlaxoSmithKline, Stevenage, SG1 2NY, UK., Lee LC; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.; Amgen, Thousand Oaks, CA, 91320, USA., Prokoph N; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Jahangiri L; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Reynolds CP; Cancer Center, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, 79430, USA., Amos Burke GA; Department of Paediatric Oncology, Box 181, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, UK., Probst NA; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Han M; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.; OncoSec, San Diego, CA, 92121, USA., Matthews JD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Lim HK; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Manners E; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Martinez S; Experimental Therapeutics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Pastor J; Experimental Therapeutics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Blanco-Aparicio C; Experimental Therapeutics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Merkel O; Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria., de Los Fayos Alonso IG; Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria., Kodajova P; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria., Tangermann S; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria., Högler S; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria., Luo J; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20814, USA., Kenner L; Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria.; Christian Doppler Laboratory for Applied Metabolomics (CDL-AM), Boltzmanngasse 20, Medical University of Vienna, Vienna, 1090, Austria., Turner SD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Lab Block level 3, Box 231, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. sdt36@cam.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2019 Nov 28; Vol. 10 (1), pp. 5428. Date of Electronic Publication: 2019 Nov 28.
Autor:
Zhang C; a School of Clinical Medicine , University of Cambridge , Cambridge , UK., Amos Burke GA; b Department of Paediatric Haematology, Oncology and Palliative Care , Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust , Cambridge , UK.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2018 Aug; Vol. 59 (8), pp. 1807-1813. Date of Electronic Publication: 2017 Oct 12.
Autor:
Amos Burke GA; Department of Oncology, Bristol Royal Hospital for Children, Bristol, UKCCSG, UK. Amos.Burke@Bristol.ac.uk, Imeson J, Hobson R, Gerrard M
Publikováno v:
British journal of haematology [Br J Haematol] 2003 May; Vol. 121 (4), pp. 586-91.